Clients who are obtaining cyclosporine, tacrolimus or other agents to stop graft-vs .-host ailment publish bone marrow transplant usually are not qualified for this demo Experimental: Dose expansion_sub-population 2_higher dose of niraparib MTDs and/or candidate RP2Ds for elimusertib utilised in combination with niraparib at the next fastened dose. Just after https://bilobetin14567.dbblog.net/58758533/5-simple-statements-about-uprosertib-explained